The bromodomain inhibitor JQ1 resulted in rapid paraprotein regressions and improved survival outcome in transplanted Vk∗MYC mice, and it was shown to diminish IFNγ-induced PD-L1 expression on human and mouse tumor cell lines [171]. The gene discussed is CD274; the disease is neoplasm.